Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RUBRA MEDICA Share Price   (RBRM)



Here is the latest stock price and chart of RUBRA MEDICA. For more details, see the RUBRA MEDICA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since such stocks interest you, here's a proven approach to making penny stock investments.

Revealing Soon: A Potential Huge Investing Opportunity for Investors

REFRESH
Live BSE Quotes May 23, 2024 01:36:00 PM
Price (Rs)9.85 Open (Rs) 9.88 High (Rs) 9.88 Low (Rs) 9.85
% Change-0.30 Volume 61 Value (Rs) 601 52-Week H/L 12.39 / 3.76
Live NSE Quotes
Not listed
Change
1 Day
-0.30%
1 Month
2.50%
3 Months
10.43%
1 Year
109.57%
Valuation
EPS (Rs)* 0.29 P/E Ratio (x) 34.09 Market Cap (Rs m) 53.86 P/BV (x) 12.65 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

RUBRA MEDICA Share Price Today:

RUBRA MEDICA last traded price was down 0.3% to Rs 9.9 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 0.5%. And the benchmark S&P BSE SENSEX was at 74,993.1 (up 1.0%).

Over the last 30 days, the RUBRA MEDICA share price is up 3.7%. And over the last one year, RUBRA MEDICA share price is up 99.4%.

The current market capitalisation of RUBRA MEDICA stands at Rs 53.86 m. For more information, check out the list of top 100 companies in India in terms of market cap.

The promoters of RUBRA MEDICA do not hold any stake in the company as of March 2024. To know who holds the largest chunk of shares, check out the latest shareholding pattern of RUBRA MEDICA.

Before you go, here's an alert on RUBRA MEDICA you may want to take note of...

Upcoming Corporate Actions for RUBRA MEDICA

DateAnnouncementEx-Date
25-May-2024Quarterly Results-
Data Source: Equitymaster, Accord Fintech

List of All Upcoming Corporate Actions



FAQs on RUBRA MEDICA

What is the RUBRA MEDICA share price today?

The last traded price of RUBRA MEDICA was Rs 9.9 on the BSE, down 0.3% over the previous close.

What is the market cap of RUBRA MEDICA?

The current market capitalisation of RUBRA MEDICA stands at Rs 54 m.

What is the Earnings per share (EPS) of RUBRA MEDICA?

RUBRA MEDICA had an EPS of Rs 0.3 in the latest financial year.

What is the PE Ratio and PB Ratio of RUBRA MEDICA?

At the current price of Rs 9.9, RUBRA MEDICA trades at a PE ratio of 34.09 while its PB ratio stands at 12.65.

Which are the top pharmaceuticals companies in India by marketcap?

Based on marketcap, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest pharmaceuticals companies in India by sales?

Based on sales, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest pharmaceuticals companies in India by net profit?

Based on net profit, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8% Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8%(10:30 am)

Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.